Eisai
4523.T
#1960
Rank
A$12.49 B
Marketcap
$44.29
Share price
0.95%
Change (1 day)
-25.78%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): A$0.66 Billion

According to Eisai's latest financial reports the company's current earnings are A$5.06 Billion. In 2023 the company made an earning of A$0.86 Billion, an increase over its 2022 earnings that were of -A$37.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.66 B-23.46%
2023 A$0.86 B-2392.87%
2022 -A$37.84 Million-103.6%
2021 A$1.05 B-39.52%
2020 A$1.73 B7.3%
2019 A$1.61 B17.23%
2018 A$1.38 B86.06%
2017 A$0.74 B-23.64%
2016 A$0.97 B27.28%
2015 A$0.76 B22.08%
2014 A$0.62 B-46.11%
2013 A$1.16 B-21.67%
2012 A$1.48 B-20.72%
2011 A$1.87 B-8.44%
2010 A$2.04 B18.85%
2009 A$1.71 B